Clinical Trials
All Clinical Trials - Page 10 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06643728Phase 2Active Not Recruiting
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Tirzepatide
- NCT06818292N/ACompleted
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
Liraglutide
- NCT06519656Phase 1/Phase 2Recruiting
Efficacy of Mazdutide for Treating PCOS
Mazdutide
- NCT06607926N/ANot Yet Recruiting
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
Thymosin-Alpha-1
- NCT06637189Phase 4Not Yet Recruiting
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Gonadorelin
- NCT06888167N/ARecruiting
Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
Exenatide
- NCT06635057Phase 4Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Tirzepatide
- NCT06500143N/ACompleted
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Semaglutide
- NCT06579105Phase 2Completed
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
Semaglutide
- NCT06606821Phase 4Recruiting
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Tirzepatide
- NCT07088718N/ACompleted
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Tirzepatide
- NCT07096063N/ACompleted
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
Tirzepatide
- NCT06613854Phase 4Recruiting
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Semaglutide
- NCT06564441Phase 1Completed
A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
Survodutide
- NCT05202353Phase 1Recruiting
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Semaglutide
- NCT06588283Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Tirzepatide
- NCT06269120N/ARecruiting
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Semaglutide
- NCT05663515N/ARecruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Exenatide
- NCT06640972Phase 2Completed
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
Tirzepatide
- NCT06396416Phase 4Recruiting
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Semaglutide
- NCT06588296Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Tirzepatide
- NCT06603571Phase 2Active Not Recruiting
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Tirzepatide
- NCT06380426N/ARecruiting
A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
Semaglutide
- NCT06605703Phase 4Completed
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
Tirzepatide
- NCT06571383Phase 4Active Not Recruiting
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Semaglutide
- NCT06632444Phase 3Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Survodutide
- NCT06485089N/ACompleted
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
Tirzepatide
- NCT06584916Phase 3Completed
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Orforglipron
- NCT07280403N/ACompleted
Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss
Semaglutide
- NCT06446531Phase 1Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk
Semaglutide
- NCT06484114N/AActive Not Recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Tirzepatide
- NCT06557811Phase 4Not Yet Recruiting
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
Semaglutide
- NCT06573398Phase 2Not Yet Recruiting
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
Thymosin-Alpha-1
- NCT06584006Phase 2Recruiting
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Thymosin-Alpha-1
- NCT06449235Phase 4Not Yet Recruiting
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Semaglutide
- NCT06497595N/ANot Yet Recruiting
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Semaglutide
- NCT06536023Phase 1Completed
This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
Mazdutide
- NCT06449625Phase 2Not Yet Recruiting
Semaglutide in Auto-HSCT
Semaglutide
- NCT06492135Phase 1Completed
A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
Survodutide
- NCT06565611Phase 2Active Not Recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Tirzepatide
- NCT06252623Phase 1Withdrawn
Exenatide For Reducing the Reinforcing Effects of Cocaine
Exenatide
- NCT06422624Phase 1Unknown
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
Semaglutide
- NCT06555146N/ANot Yet Recruiting
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
Semaglutide
- NCT06559722Phase 3Not Yet Recruiting
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
Liraglutide
- NCT06533527Phase 4Completed
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
Tirzepatide
- NCT06501729N/ACompleted
Kissing as a Protective Factor Against Acidic pH in Saliva
Kisspeptin
- NCT06379217Phase 1Active Not Recruiting
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
Gonadorelin
- NCT06492330N/ACompleted
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
Semaglutide
- NCT06257966Phase 3Active Not Recruiting
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Dulaglutide
- NCT06455969Phase 4Recruiting
Adaptions and Resiliency to Multi-Stressor OpeRations
Gonadorelin